The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subset analysis of COMPASS: A randomized 2X2 phase II trial comparing two and four courses of S-1/cisplatin (SC) and paclitaxel/cisplatin (PC) as neoadjuvant chemotherapy for locally advanced gastric cancer.
 
Takaki Yoshikawa
Honoraria - Abbott Diagnostics; Chugai Pharma; Covidien; Johnson & Johnson; Kaken Pharmaceutical; Lilly Japan; Ono Pharmaceutical; Secom Medical System; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - Novartis
Research Funding - Chugai Pharma (Inst); Covidien (Inst); Daiichi Sankyo (Inst); Nippon Kayaku (Inst); Ono Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Kazuaki Tanabe
No Relationships to Disclose
 
Yuichi Ito
No Relationships to Disclose
 
Kazuhiro Nishikawa
Honoraria - Ajinomoto; Chugai Pharma; Taiho Pharmaceutical; TERUMO; Tsumura & Co.; Yakult Pharmaceutical
Research Funding - Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Kazumasa Fujitani
No Relationships to Disclose
 
Takanori Matsui
No Relationships to Disclose
 
Tsutomu Hayashi
No Relationships to Disclose
 
Toru Aoyama
No Relationships to Disclose
 
Haruhiko Cho
Honoraria - Novartis; Pfizer
 
Satoshi Morita
Honoraria - Bristol-Myers Squibb Japan; Taiho Pharmaceutical
 
Yumi Miyashita
No Relationships to Disclose
 
Akira Tsuburaya
No Relationships to Disclose
 
Junichi Sakamoto
No Relationships to Disclose